ALNY - Alnylam Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALNY is currently covered by 26 analysts with an average price target of $271.07. This is a potential upside of $36.23 (15.43%) from yesterday's end of day stock price of $234.84.

Alnylam Pharmaceuticals's activity chart (see below) currently has 346 price targets and 352 ratings on display. The stock rating distribution of ALNY is 31.3% HOLD and 68.7% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.27% with an average time for these price targets to be met of 234.38 days.

Highest price target for ALNY is $400, Lowest price target is $170, average price target is $271.07.

Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 12-Jul-2024.

Currently out of the existing stock ratings of ALNY, 36 are a HOLD (31.3%), 79 are a BUY (68.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

255

$17.17 (7.22%)

250

14 days ago

8/8 (100%)

$-5.51 (-2.12%)

41

Buy

357

$119.17 (50.11%)

283

18 days ago

1/7 (14.29%)

$101.89 (39.94%)

338

Buy

295

$57.17 (24.04%)

240

29 days ago

16/17 (94.12%)

$48 (19.43%)

255

Buy

265

$27.17 (11.42%)

250

29 days ago

8/16 (50%)

$18 (7.29%)

214

Hold

207

$-30.83 (-12.96%)

161

1 months 1 days ago

2/3 (66.67%)

$-33.15 (-13.80%)

5

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALNY (Alnylam Pharmaceuticals) average time for price targets to be met?

On average it took 234.38 days on average for the stock forecasts to be realized with a an average price target met ratio 84.27

Which analyst has the current highest performing score on ALNY (Alnylam Pharmaceuticals) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on ALNY (Alnylam Pharmaceuticals)?

Madhu Kumar works at GOLDMAN SACHS and has 2 price targets and 1 ratings on ALNY

Which analyst is the currently most bullish on ALNY (Alnylam Pharmaceuticals)?

Patrick Trucchio with highest potential upside - $162.17

Which analyst is the currently most reserved on ALNY (Alnylam Pharmaceuticals)?

Christopher Marai with lowest potential downside - -$163.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?